Publication update – National SACT Breast regimen specific consent forms

New consent forms for breast cancer have been added to the CRUK website at www.cruk.org/sact_consent. Some existing forms have been updated as well.

The new regimens include:

1. Alpelisib

2. Olaparib

3. Pembrolizumab – Carboplatin – Paclitaxel – EC

4. Pembrolizumab and Paclitaxel

5. Pembrolizumab and Paclitaxel Albumin-Bound

6. Sacituzumab Govitecan

Regimens that have been updated include:

1. Capecitabine

2. Neratinib

3. Palbociclib

4. Ribociclib

5. Trastuzumab

6. Vinorelbine

7. Vinorelbine and Capecitabine

Please share this update within your clinical teams or forward to the relevant lead cancer clinician for your organisation.

Any questions, please do let me know.

Best wishes,

Alia

Alia Nizam |Specialist Oncology Pharmacist. CRUK – Information Lead|

Guy’s and St Thomas’ NHS Foundation Trust